reference/8872202

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8872202

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Clinical Trial, Phase III\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	275
issn	2159-3345 2159-3337
issueIdentifier	5
pageRange	265-275
publicationName	Nucleic Acid Therapeutics
startingPage	265
bibliographicCitation	Yu RZ, Wang Y, Norris DA, Kim T, Narayanan P, Geary RS, Monia BP, Henry SP. Immunogenicity Assessment of Inotersen, a 2′-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety. Nucleic Acid Therapeutics. 2020 Oct 01;30(5):265–75. doi: 10.1089/nat.2020.0867.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09f3d28b3021e35658ac7002adc94dbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d18b8ececd1e79436142296cd3a491b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd7593f0f8a1ec4ebef6a62e45c653cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b8ebbcff6aa58e4c15932dc7d764899 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_536085ee83bb310d49d50cea9161a802 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60b850c82195ffaa876d37d940644fa7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d16666ecc76770bcace8865d84b15ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d631a6b728bd988c34a60a10c25da3eb
date	2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1089/nat.2020.0867 https://pubmed.ncbi.nlm.nih.gov/32833564
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39275 https://portal.issn.org/resource/ISSN/2159-3337 https://portal.issn.org/resource/ISSN/2159-3345
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Immunogenicity Assessment of Inotersen, a 2′-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety
discusses	http://id.nlm.nih.gov/mesh/M0025055 http://id.nlm.nih.gov/mesh/M0015278 http://id.nlm.nih.gov/mesh/M0015280 http://id.nlm.nih.gov/mesh/M0001324 http://id.nlm.nih.gov/mesh/M0305798 http://id.nlm.nih.gov/mesh/M000646654 http://id.nlm.nih.gov/mesh/M0017446 http://id.nlm.nih.gov/mesh/M000647713
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011228Q000235 http://id.nlm.nih.gov/mesh/D016376Q000008 http://id.nlm.nih.gov/mesh/D002607Q000188 http://id.nlm.nih.gov/mesh/D009841Q000008 http://id.nlm.nih.gov/mesh/D009843Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000071497Q000235 http://id.nlm.nih.gov/mesh/D016376Q000009 http://id.nlm.nih.gov/mesh/D009841Q000009 http://id.nlm.nih.gov/mesh/D002607Q000097 http://id.nlm.nih.gov/mesh/D064420Q000473 http://id.nlm.nih.gov/mesh/D009843Q000493 http://id.nlm.nih.gov/mesh/D000071497Q000276 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007677 http://id.nlm.nih.gov/mesh/D011228Q000037 http://id.nlm.nih.gov/mesh/D009843Q000097 http://id.nlm.nih.gov/mesh/D016376Q000097 http://id.nlm.nih.gov/mesh/D001792Q000276 http://id.nlm.nih.gov/mesh/D009843Q000009 http://id.nlm.nih.gov/mesh/D064420Q000276 http://id.nlm.nih.gov/mesh/D016376Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D011228Q000276 http://id.nlm.nih.gov/mesh/D000888Q000097 http://id.nlm.nih.gov/mesh/D000882 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000888Q000276 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_da1ca8f34cf9fa260557c3847aa16ec1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8936

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7276

Total number of triples: 68.